XOMA Co. (NASDAQ:XOMAP) Sees Large Increase in Short Interest

XOMA Co. (NASDAQ:XOMAP) was the target of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling 1,232 shares, an increase of 96.5% from the January 29th total of 627 shares. Based on an average daily trading volume, of 674 shares, the short-interest ratio is currently 1.8 days. Based on an average daily trading volume, of 674 shares, the short-interest ratio is currently 1.8 days.

XOMA Trading Up 0.1%

Shares of XOMA stock opened at $25.89 on Friday. The business has a 50-day moving average price of $26.38 and a two-hundred day moving average price of $26.39. XOMA has a 1-year low of $24.96 and a 1-year high of $30.00.

About XOMA

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.